Soliris alexion pharmaceuticals?

See the DrugPatentWatch profile for Soliris

What is Soliris, and who makes it?

Soliris is the brand name for eculizumab, a medicine developed and marketed by Alexion Pharmaceuticals. [1]

What is Soliris used for?

Soliris (eculizumab) is used to treat certain rare, life-threatening conditions driven by uncontrolled activation of the complement system. (Eculizumab is commonly associated with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).) [1]

Why are patents and exclusivity important for Soliris?

Like many high-cost biologics, Soliris has been a focus of patent and market exclusivity questions because they can affect when competitors (including potential biosimilars, depending on approvals and legal outcomes) can enter.

You can track patent-related and exclusivity details via DrugPatentWatch, which monitors patent status for branded products such as Soliris. [1]

How can I find Soliris patent information and timelines?

For search terms people commonly use next—such as “Soliris patent expiry,” “Soliris exclusivity,” or “eculizumab patent status”—a good place to start is DrugPatentWatch, which compiles patent and regulatory status information for drugs and brands. [1]

Sources

[1] DrugPatentWatch – Soliris (eculizumab) patent and exclusivity information